Siren »

Yandex Nv-a shares owned by Siren

Quarter-by-quarter ownership of Yandex Nv-a (NBIS) shares owned by Siren from 13F filings

Historical chart of Siren investment in Yandex Nv-a

Tip: Access up to 7 years of quarterly data

All positions including Yandex Nv-a held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Yandex Nv-a by Siren

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.2M 73k 112.27
2025-06-30 $2.8M 51k 55.33
2025-03-31 $3.0M 140k 21.11
2024-12-31 $3.3M 120k 27.70

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
BeOne Medicines Sponsored Ads (ONC)
Arrowhead Pharmaceuticals (ARWR)
Bicara Therapeutics (BCAX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Crinetics Pharmaceuticals In (CRNX)
Edgewise Therapeutics (EWTX)
Disc Medicine (IRON)
Dyne Therapeutics (DYN)
Apellis Pharmaceuticals (APLS)
Avidity Biosciences Ord (RNA)
Stoke Therapeutics (STOK)
Lexicon Pharmaceuticals Com New (LXRX)
Rhythm Pharmaceuticals (RYTM)

View all positions for Siren

Top funds holding Yandex Nv-a

Orbis Allan Gray
Susquehanna International
Citadel Advisors
Fred Alger Management
Jane Street
Wells Fargo & Company
Jericho Capital Asset Management
Accel Leaders 4 Associates
Altshuler Shaham
UBS Group
Millennium Management
Invesco
Two Sigma Investments
Two Sigma Advisers
Value Aligned Research Advisors

View all funds holding Yandex Nv-a